NCT04771221

Brief Summary

The investigator will issue a Patient Information Consent for the participant in the study. 1.Patients will be asked to complete the Reflux Symptom Index questionnaire. Clinical survey, medical history. 2. Objective methods for assessing the patient's condition: \- examination of ENT organs. 3. Laboratory and instrumental research methods: Endoscopic laryngoscopy and video laryngoscopy, pH-metry, acoustic voice analysis. 4.Sociological method. 5. Subjective methods for assessing the condition of the larynx. 6. Аnalysis of the received data

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
385

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2021

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

February 23, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 25, 2021

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2022

Completed
Last Updated

January 10, 2023

Status Verified

April 1, 2022

Enrollment Period

1.1 years

First QC Date

February 23, 2021

Last Update Submit

January 6, 2023

Conditions

Keywords

Laryngopharyngeal RefluxLaryngopharyngitis ChronicGastro Esophageal RefluxLaryngitispH monitoringpH metricacoustic voice analysis

Outcome Measures

Primary Outcomes (10)

  • Acidity level of the main group, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    at the inclusion to the study

  • Acidity level of the control group 1, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    at the inclusion to the study

  • Acidity level of the control group 2, Week 0

    The acidity level of the larynx is assessed using litmus paper. The range of acidity levels is from 4.5 to 9.0, where below 6.5 indicates the acidity of the environment, above 7.5 - alkalinity.

    at the inclusion to the study

  • "Index of reflux symptoms" of the main group, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    at the inclusion to the study

  • "Index of reflux symptoms" of the control group 1, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    at the inclusion to the study

  • "Index of reflux symptoms" of the control group 2, Week 0

    Patients will be asked to complete the Reflux Symptom Index questionnaire. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. The severity of the problem is calculated as the summation of all points. The problem is absent if the summation of points is 0. The problem is serious if the summation of points is 5.

    at the inclusion to the study

  • Endoscopic laryngoscopy of the main group, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    at the inclusion to the study

  • Endoscopic laryngoscopy of the control group 1, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    at the inclusion to the study

  • Endoscopic laryngoscopy of the control group 2, Week 0

    Assessment of the state of the larynx on the scale of reflux symptoms. Where the presence and severity of the sign is assessed in points from 0 to 4. Where 0 is an indicator of no problem, and 4 is an indicator of a serious problem.

    at the inclusion to the study

  • Acoustic voice analysis of the main group, Week 0

    Acoustic analysis of the voice was performed in patients with a voice profession who had a voice disorder using computer program of the Lingwaves.

    at the inclusion to the study

Secondary Outcomes (10)

  • Acidity level of the main group, Week 4

    at 4 weeks after initial treatment

  • Acidity level of the control group 1, Week 4

    at 4 weeks after initial treatment

  • Acidity level of the control group 2, Week 4

    at 4 weeks after initial treatment

  • "Index of reflux symptoms" of the main group, Week 4

    at 4 weeks after initial treatment

  • "Index of reflux symptoms" of the control group 1, Week 4

    at 4 weeks after initial treatment

  • +5 more secondary outcomes

Study Arms (3)

Main group

EXPERIMENTAL

Patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.

Diagnostic Test: pH metryDiagnostic Test: Filling out the questionnaireDevice: Endoscopic laryngoscopyDevice: Acoustic voice analysis

Control group 1

EXPERIMENTAL

Patients with an early diagnosis of Gastroesophageal reflux disease

Diagnostic Test: pH metryDiagnostic Test: Filling out the questionnaireDevice: Endoscopic laryngoscopy

Control group 2

EXPERIMENTAL

Patients without complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching.

Diagnostic Test: pH metryDiagnostic Test: Filling out the questionnaireDevice: Endoscopic laryngoscopy

Interventions

pH metryDIAGNOSTIC_TEST

The collection of mucus from the laryngopharynx to determine the acid-base values through pH-metry.

Control group 1Control group 2Main group

Completion of the questionnaire index of reflux symptoms. An analysis of the results of the effectiveness of this method in patients with complaints of sore throat, coughing, burning sensation in the throat, cough, frequent sore throat, difficulty swallowing, lump in the throat, feeling of a foreign body in the throat, voice change, heartburn, belching will be carried out. Evaluation results range from 0 to 5, where 0 is an indicator of no problem, and 5 is an indicator of a serious problem

Control group 1Control group 2Main group

Video laryngoscopy and assessment of the presence / severity of the symptoms. Evaluation results range from 0 to 4, where 0 is an indicator of no problem, and 4 is an indicator of a serious problem

Control group 1Control group 2Main group

acoustic analysis of the voice was performed in singers with voice disorders before and after treatment using program of the Lingwaves

Main group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient's informed consent
  • Age: 18-75 years old
  • No serious somatic diseases.
  • Patients with complaints of sore throat, coughing, burning sensation in the throat, coughing, frequent sore throat, difficulty swallowing, lump in the throat, foreign body feeling in the throat, voice changes, heartburn and belching.
  • Diagnosis: Chronic pharyngitis
  • Chronic laryngitis

You may not qualify if:

  • Disagreement to participate in scientific research
  • Age: under 18 and over 76
  • Severe somatic diseases, organic lesions of the gastrointestinal tract and ENT organs
  • Patients with pulmonary pathologies
  • Patients with allergic manifestations (seasonal hay fever, asthma, etc.)
  • With diagnoses: Acute respiratory diseases
  • Patients with general neuralgic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

SOS Medical Assistance

Almaty, Kazakhstan

Location

V-ent

Almaty, Kazakhstan

Location

MeSH Terms

Conditions

Laryngopharyngeal RefluxGastroesophageal RefluxLaryngitis

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesLaryngeal DiseasesRespiratory Tract DiseasesRespiratory Tract InfectionsInfectionsOtorhinolaryngologic Diseases

Study Officials

  • Nukusbekova

    Doctor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2021

First Posted

February 25, 2021

Study Start

January 10, 2021

Primary Completion

February 15, 2022

Study Completion

February 15, 2022

Last Updated

January 10, 2023

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations